Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections

Expert Opin Pharmacother. 2019 Jun;20(8):903-907. doi: 10.1080/14656566.2019.1594774. Epub 2019 Mar 25.

Authors

Bryan T Mogle¹, Mario V Beccari¹, Jeffrey M Steele^{1

2}, Tasaduq Fazili², Wesley D Kufel^{1

2

3}

Affiliations

¹ a Department of Pharmacy , State University of New York Upstate University Hospital , Syracuse , NY , USA.
² b Department of Medicine , State University of New York Upstate Medical University , Syracuse , NY , USA.
³ c Department of Pharmacy Practice , Binghamton University School of Pharmacy and Pharmaceutical Sciences , Binghamton , NY , USA.

PMID: 30908107
DOI: 10.1080/14656566.2019.1594774

No abstract available

Keywords: Enterobacteriaceae; Gram-negative; Oral beta-lactam; bacteremia; bloodstream infections; pharmacodynamics; pharmacokinetics.

Publication types

Editorial